Eli Lilly’s diabetes drug tirzepatide gets approval in China
ELI Lilly said on Tuesday (May 21) its diabetes drug tirzepatide has received approval from Chinese regulators, setting up intensifying ...
Tag: Lillys
Lilly’s US$2.5 billion German plant will boost obesity-drug supply
ELI Lilly kicked off construction of a new plant to boost the production of its wildly popular weight-loss drugs, which ...
Lilly’s climb has analysts asking US$1 trillion question
ELI Lilly & Co’s relentless stock records have Morgan Stanley analysts musing whether it will become the first US company ...
Forbes 40under40 stands as a distinguished platform revered for its commitment to honoring and applauding the remarkable achievements of exceptional individuals who have yet to reach the age of 40. This esteemed initiative serves as a beacon of inspiration, spotlighting trailblazers across various industries and domains, showcasing their innovation, leadership, and impact on a global scale.
© 2024 Forbes 40under40. All Rights Reserved.